| Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution MV Uthaug, K van Oorsouw, KPC Kuypers, M Van Boxtel, NJ Broers, ... Psychopharmacology 235, 2979-2989, 2018 | 196 | 2018 |
| Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin NL Mason, KPC Kuypers, F Müller, J Reckweg, DHY Tse, SW Toennes, ... Neuropsychopharmacology 45 (12), 2003-2011, 2020 | 180 | 2020 |
| A single inhalation of vapor from dried toad secretion containing 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of … MV Uthaug, R Lancelotta, K Van Oorsouw, KPC Kuypers, N Mason, J Rak, ... Psychopharmacology 236 (9), 2653-2666, 2019 | 167 | 2019 |
| Sub-acute effects of psilocybin on empathy, creative thinking, and subjective well-being NL Mason, E Mischler, MV Uthaug, KPC Kuypers Journal of psychoactive drugs 51 (2), 123-134, 2019 | 148 | 2019 |
| Psychedelics and neuroplasticity: a systematic review unraveling the biological underpinnings of psychedelics CMH De Vos, NL Mason, KPC Kuypers Frontiers in psychiatry 12, 724606, 2021 | 144 | 2021 |
| Motives and side-effects of microdosing with psychedelics among users NRPW Hutten, NL Mason, PC Dolder, KPC Kuypers International Journal of Neuropsychopharmacology 22 (7), 426-434, 2019 | 120 | 2019 |
| Low doses of LSD acutely increase BDNF blood plasma levels in healthy volunteers NRPW Hutten, NL Mason, PC Dolder, EL Theunissen, F Holze, ME Liechti, ... ACS pharmacology & translational science 4 (2), 461-466, 2020 | 102 | 2020 |
| Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study NRPW Hutten, NL Mason, PC Dolder, EL Theunissen, F Holze, ME Liechti, ... European Neuropsychopharmacology 41, 81-91, 2020 | 94 | 2020 |
| Spontaneous and deliberate creative cognition during and after psilocybin exposure NL Mason, KPC Kuypers, JT Reckweg, F Müller, DHY Tse, B Da Rios, ... Translational psychiatry 11 (1), 209, 2021 | 82 | 2021 |
| A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats MV Uthaug, NL Mason, SW Toennes, JT Reckweg, ... Psychopharmacology 238, 1899-1910, 2021 | 78 | 2021 |
| A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers JG Ramaekers, N Hutten, NL Mason, P Dolder, EL Theunissen, F Holze, ... Journal of Psychopharmacology 35 (4), 398-405, 2021 | 75 | 2021 |
| Self-rated effectiveness of microdosing with psychedelics for mental and physical health problems among microdosers NRPW Hutten, NL Mason, PC Dolder, KPC Kuypers Frontiers in psychiatry 10, 481074, 2019 | 72 | 2019 |
| Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses E Drummond, W McCulloch, GM Knudsen, FS Barrett, MK Doss, ... Neuroscience & Biobehavioral Reviews 138, 104689, 2022 | 62 | 2022 |
| Blunted highs: Pharmacodynamic and behavioral models of cannabis tolerance JG Ramaekers, NL Mason, EL Theunissen European Neuropsychopharmacology 36, 191-205, 2020 | 59 | 2020 |
| Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity NL Mason, EL Theunissen, NRPW Hutten, HY Desmond, SW Toennes, ... European Neuropsychopharmacology 29 (2), 247-256, 2019 | 57 | 2019 |
| The why behind the high: determinants of neurocognition during acute cannabis exposure JG Ramaekers, NL Mason, L Kloft, EL Theunissen Nature Reviews Neuroscience 22 (7), 439-454, 2021 | 47 | 2021 |
| The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N, N‐dimethyltryptamine (5‐MeO‐DMT) JT Reckweg, MV Uthaug, A Szabo, AK Davis, R Lancelotta, NL Mason, ... Journal of Neurochemistry 162 (1), 128-146, 2022 | 46 | 2022 |
| Reduced responsiveness of the reward system is associated with tolerance to cannabis impairment in chronic users NL Mason, EL Theunissen, NRPW Hutten, DHY Tse, SW Toennes, ... Addiction biology 26 (1), e12870, 2021 | 46 | 2021 |
| Pharmacokinetics and pharmacodynamics of lysergic acid diethylamide microdoses in healthy participants F Holze, ME Liechti, NRPW Hutten, NL Mason, PC Dolder, EL Theunissen, ... Clinical Pharmacology & Therapeutics 109 (3), 658-666, 2021 | 40 | 2021 |
| Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH‐018: a phase 1, placebo‐controlled, pilot study EL Theunissen, NRPW Hutten, NL Mason, SW Toennes, KPC Kuypers, ... British journal of pharmacology 175 (1), 18-28, 2018 | 39 | 2018 |
Kim PC KuypersAssociate ProfessorVerified email at maastrichtuniversity.nl
